2013 Articles
2012 Articles
2011 Articles
2010 Articles
2009 Articles
The FDA is currently reviewing recent reports of children who developed serious adverse effects or died after taking codeine for post-surgical pain relief. Three children died and one child developed life-threatening respiratory depression after taking codeine. All four children used codeine for pain after having their tonsils and/or adenoids removed for treatment of obstructive sleep apnea. The children were given appropriate doses of codeine, but were found upon genetic testing to be “ultra-rapid metabolizers” of codeine, which resulted in overdose.
Codeine is not active as an analgesic until it is converted to morphine in the liver. The enzyme that converts codeine to morphine is called cytochrome P450 2D6 (CYP2D6). There is a wide genetic variation in the level of activity of CYP2D6. Some people have fairly inactive CYP2D6 enzymes, so they don’t get much pain relief from codeine (they are called “poor metabolizers”). Others, like the children described above, have extremely active CYP2D6 enzymes, so they may be prescribed an appropriate dose of codeine, but end up with much higher levels of morphine in their blood – and overdose can result. It is hypothesized that these particular children, with a history of sleep apnea, were already at a higher risk of fatal respiratory depression from opioids.
Ethnicity is a factor in CYP2D6 variability. In most populations, 1-7% of people are ultra-rapid metabolizers of codeine. But in Africans, as much as 29% of the population are ultra-rapid metabolizers. On the flip side, approximately 6-10% of Caucasians are poor metabolizers; the percentage is slightly higher in African-Americans and slightly lower in Asians.
The FDA is reviewing the safety reports about codeine, and looking at the use of codeine in other patients and other settings, and said it will provide a public update when the process is complete. In the meantime, healthcare professionals should be aware of the risks of using codeine in children, and should perhaps consider other drugs instead of codeine. If prescribing codeine-containing drugs, the lowest effective dose for the shortest period of time should be used on an as-needed basis (i.e., not scheduled around the clock). Parents and caregivers who observe unusual sleepiness, confusion, or difficult or noisy breathing in their child should seek medical attention immediately, as these are signs of overdose.
A huge challenge facing parents, caregivers and healthcare professionals who take care of ill children is getting those children to take their medicine. When children won’t take their medicine, optimal care is obviously challenged, whether in a chronically ill child who must take routine medicine to control their disease or in an acutely ill child who must take an as-needed medication to control symptoms. In this article, I’d like to present some strategies, which can be employed by anyone caring for an ill child, for getting kids to take medications.
Dealing with Bad Flavor
Medicines, especially liquids, are notorious for tasting bad. When flavor is an issue, try the following:
Strategies for Toddlers and Older Kids
Like most things with toddlers and older kids, medicine-taking can quickly become a turf war, resulting in a lot of stress and fighting. To avoid getting to that point, try these strategies:
With all children, anticipate and prevent side effects as much as possible. Children make strong and fast associations, so even one negative experience may create a difficult situation where the child no longer wants to take the medicine.
What strategies have you found useful in getting children to take their medicine?
Currently, pediatric acetaminophen is available in two liquid concentrations: 160 mg per 5 mL (usually labeled as “children’s”) and 160 mg per 1.6 mL (usually labeled as “infants’”, as it is given in drop form). The availability of two concentrations has resulted in confusion and dosing errors, and has been a long-standing source of concern.
In May of this year, the Consumer Healthcare Products Association (CHPA) announced an industry-wide transition to a single pediatric acetaminophen concentration. Companies are voluntarily shifting to the 160 mg per 5 mL concentration. Eventually, the more concentrated infants’ drops will no longer be available. This shift is consistent with an FDA Advisory Committee recommendation made in 2009.
Pediatric acetaminophen dosing remains 10-15 mg/kg/dose.
Dosing chart for liquid pediatric acetaminophen products
Patient weight (lb) |
Typical patient age (mo) |
Dose (mL) for older, more concentrated products (160 mg per 1.6 mL) |
Dose (mL) for uniform concentration products (160 mg per 5 mL) |
6-11 |
0-3 |
0.4 |
1.25 |
12-17 |
4-11 |
0.8 |
2.5 |
18-23 |
12-23 |
1.2 |
3.75 |
24-35 |
24-36 |
1.6 |
5 |
Outcome Resources is a pharmacy partner exclusively for hospices with experienced pediatric palliative care pharmacists on staff and available for consultation to our hospice clients. If you are interested in learning more about how a partnership with Outcome Resources can benefit your hospice, including your pediatric palliative care program, Contact Us today.
"
| Shelley Bloyd - This is the most beautiful ltlite girl I have seen!!!! Of course, I might be prejudiced since it is my granddaughter. What beautiful pictures and I can't wait to see the rest.June 2, 2009 3:53 pm -- Arun Posted 8/6/2012 12:08:36 AM |
This final article in our pediatric series will focus on the management of some of the most common non-pain symptoms encountered in pediatric palliative care. Research is notoriously lacking in this area, so much of what is done in pediatric palliative care is derived from the general pediatric population, from adult palliative care, or simply from clinical experience.
Specific symptom complexes that are addressed include: anxiety & depression, agitation, insomnia, anorexia-cachexia, nausea-vomiting, constipation, and dyspnea. Specific medication strategies will be presented for managing each of these troubling symptoms in pediatric hospice patients.

"
| That takes us up to the next level. Great psoitng. -- Maud Posted 4/3/2013 01:07:18 AM |
| First 10 | <<Previous 10 | Next 10 >> | Last 10 |
Education Resources and Support for HospicesStay up-to-date on the latest hospice pharmacy benefits management information and tools with a variety of education resources and support at no extra charge. We offer presentations live at your facility, over the Internet or via |
![]() |
![]() |
Why Use A PBM?Contracting with multiple pharmacies, doing all the reporting, trying to stay current with medical practices and stay compliant while keeping costs down? There’s an easier and more effective way. Find out how using a pharmacy benefits manager (PBM) can help you>>
|

